TY - JOUR
T1 - Access to Medications for Opioid Use Disorder in Rural Versus Urban Veterans Health Administration Facilities
AU - Wyse, Jessica J.
AU - Shull, Sarah
AU - Lindner, Stephan
AU - Morasco, Benjamin J.
AU - Gordon, Adam J.
AU - Carlson, Kathleen F.
AU - Korthuis, P. Todd
AU - Ono, Sarah S.
AU - Liberto, Joseph G.
AU - Lovejoy, Travis I.
N1 - Funding Information:
This work was supported by the U.S. Department of Veterans Affairs Health Services Research and Development (IK2HX003007) and resources from the VA Health Services Research and Development-funded Center to Improve Veteran Involvement in Care at the VA Portland Health Care System (CIN 13-404). No author reports having any potential conflict of interest with this study.
Publisher Copyright:
© 2023, This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.
PY - 2023
Y1 - 2023
N2 - Background: For patients with opioid use disorder (OUD), medications for OUD (MOUD) reduce morbidity, mortality, and return to use. Nevertheless, a minority of patients receive MOUD, and underutilization is pronounced among rural patients. Objective: While Veterans Health Administration (VHA) initiatives have improved MOUD access overall, it is unknown whether access has improved in rural VA health systems specifically. How “Community Care,” healthcare paid for by VHA but received from non-VA providers, has affected rural access is also unknown. Design: Data for this observational study were drawn from the VHA Corporate Data Warehouse. Facility rurality was defined by rural-urban commuting area code of the primary medical center. International Classification of Diseases codes identified patients with OUD within each year, 2015–2020. We included MOUD (buprenorphine, methadone, extended-release naltrexone) received from VHA or paid for by VHA but received at non-VA facilities through Community Care. We calculated average yearly MOUD receipt; linear regression of outcomes on study years identified trends; an interaction between year and rural status evaluated trend differences over time. Participants: All 129 VHA Health Systems, a designation that encompasses one or more medical centers and their affiliated community-based outpatient clinics Main Measures: The average proportion of patients diagnosed with OUD that receive MOUD within rural versus urban VHA health care systems. Key Results: From 2015 to 2020, MOUD access increased substantially: the average proportion of patients receiving MOUD increased from 34.6 to 48.9%, with a similar proportion of patients treated with MOUD in rural and urban systems in all years. Overall, a small proportion (1.8%) of MOUD was provided via Community Care, and Community Care did not disproportionately benefit rural health systems. Conclusions: Strategies utilized by VHA could inform other health care systems seeking to ensure that, regardless of geographic location, all patients are able to access MOUD.
AB - Background: For patients with opioid use disorder (OUD), medications for OUD (MOUD) reduce morbidity, mortality, and return to use. Nevertheless, a minority of patients receive MOUD, and underutilization is pronounced among rural patients. Objective: While Veterans Health Administration (VHA) initiatives have improved MOUD access overall, it is unknown whether access has improved in rural VA health systems specifically. How “Community Care,” healthcare paid for by VHA but received from non-VA providers, has affected rural access is also unknown. Design: Data for this observational study were drawn from the VHA Corporate Data Warehouse. Facility rurality was defined by rural-urban commuting area code of the primary medical center. International Classification of Diseases codes identified patients with OUD within each year, 2015–2020. We included MOUD (buprenorphine, methadone, extended-release naltrexone) received from VHA or paid for by VHA but received at non-VA facilities through Community Care. We calculated average yearly MOUD receipt; linear regression of outcomes on study years identified trends; an interaction between year and rural status evaluated trend differences over time. Participants: All 129 VHA Health Systems, a designation that encompasses one or more medical centers and their affiliated community-based outpatient clinics Main Measures: The average proportion of patients diagnosed with OUD that receive MOUD within rural versus urban VHA health care systems. Key Results: From 2015 to 2020, MOUD access increased substantially: the average proportion of patients receiving MOUD increased from 34.6 to 48.9%, with a similar proportion of patients treated with MOUD in rural and urban systems in all years. Overall, a small proportion (1.8%) of MOUD was provided via Community Care, and Community Care did not disproportionately benefit rural health systems. Conclusions: Strategies utilized by VHA could inform other health care systems seeking to ensure that, regardless of geographic location, all patients are able to access MOUD.
KW - access
KW - opioid agonist
KW - opioid use disorder
KW - rural
KW - veterans
UR - http://www.scopus.com/inward/record.url?scp=85146662239&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85146662239&partnerID=8YFLogxK
U2 - 10.1007/s11606-023-08027-4
DO - 10.1007/s11606-023-08027-4
M3 - Article
AN - SCOPUS:85146662239
SN - 0884-8734
JO - Journal of General Internal Medicine
JF - Journal of General Internal Medicine
ER -